Oligogen, Inc.
The startup develops neural stem cell technologies for regenerative medicine aimed at treating central nervous system diseases, including spinal cord injuries and multiple sclerosis. By utilizing human neural stem cells as a cell therapy, the company provides targeted treatment options for conditions like Pelizaeus-Merzbacher disease.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$3.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops neural stem cell technologies for regenerative medicine aimed at treating central nervous system diseases, including spinal cord injuries and multiple sclerosis. By utilizing human neural stem cells as a cell therapy, the company provides targeted treatment options for conditions like Pelizaeus-Merzbacher disease.